The company is not falling under Large Corporate Category as on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed the BSE that as of 31st March 2025, the company does not fall under the 'Large Corporate' category as defined by SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26 November 2018. This circular governs fund-raising norms through issuance of debt securities for large entities. By confirming its non-applicability, the company is signalling that its borrowings or debt securities outstanding are below the thresholds that would classify it as a Large Corporate. The disclosure was signed by the Managing Director on 24 April 2025 and is a routine compliance filing.
This is a routine regulatory disclosure with no direct impact on shareholders or stock price. It simply confirms that the company is exempt from certain additional borrowing and disclosure obligations applicable to large corporates, meaning its debt levels remain below the large corporate threshold.